There have only been five cases of polio to date this year and the virus has been eliminated in all but three countries. Still, funders are doubling down to finish the job, putting up $1.2 billion.
Read MoreWith his annual giving now over $600 million, Bloomberg hopes to spread his no-nonsense ideas for improving global health–namely, by looking beyond trendy causes to "overlooked killers."
Read MoreClubfoot doesn’t get a lot of attention from global health funders. But one major grantmaker is stepping up here in a big way: the Oak Foundation.
Read MoreAntibiotic-resistant superbugs are killing ever more people in a trend that could have dire consequences. No funder is more worried about this threat than Wellcome Trust.
Read MoreIn another example of Bloomberg Philanthropies zeroing in on mundane but vital global health issues, the foundation is ramping up its work to prevent drowning deaths in poor countries.
Read MoreChicagoland couple Jerry and Susan Kolschowsky, who built a fortune in the food industry, support the poor and hungry near home—and in the developing world.
Read MoreContinuing our spotlight of new grantmaking action on NTDs, we look at which funders are putting up funds to combat the devastating parasitic disease schistosomiasis.
Read MoreDerek C. Schrier founded Indaba Capital Management, where he's managing partner. But a major component of his philanthropy with wife Cameron involves South Africa, where Schrier worked to end apartheid.
Read MoreNeglected tropical diseases inflict a devastating human and economic toll on poor countries. The good news? It’s been a busy year in the global fight against NTDs.
Read MoreProviding continuous access to essential medicines is a global health challenge where innovation is key—especially where the critical cold chain is concerned. Microneedles are one solution.
Read MoreWhile uninterrupted refrigeration is key to successful vaccine delivery, that's no easy thing in poor countries where electricity is spotty. Which is why one nonprofit's tech solution has some funders excited.
Read MoreSince 80 percent of blindness in the world is preventable, you might think plenty of funders would be working this problem. But that's not the case. So who is in this fight?
Read MoreIn parts of Africa, the mortality rate for pediatric cancer patients can be as high as 90 percent. Many of those deaths can be prevented, and this corporate funder is working to make that happen.
Read MoreGates recently sounded the alarm about the risks posed by weaponizing dangerous pathogens. He's not the only deep-pocketed funder who's been moving new resources to address biosecurity issues.
Read MoreWellcome Trust, the world's second-largest foundation, spends a fortune to find new health breakthroughs. Now, it's making a push to ensure that research translates into actual health gains.
Read MoreTrump's harsher version of the "global gag rule" may put huge pressures on private global health funders to fill new and gaping funding gaps. Oh, and it's also likely to actually increase abortions.
Read MoreThe latest annual letter by Bill and Melinda Gates leaves key questions unanswered about where Gates giving might go from here. With $185 billion in play, what might the future hold?
Read MoreGeography often determines a mother and her newborn’s chances of survival. Merck's philanthropic arm is set on changing that. Here's the latest.
Read MoreMajor data projects are looming ever larger in global health philanthropy. What are funders trying to find out? And are these expensive efforts the best use of grant dollars?
Read MoreIs the rapid urbanization of the world a good thing when it comes to public health, equity, and more? To find out, Wellcome Trust is funding a five-year study in hundreds of cities.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
